Steele Robin Joan

SEC source: 0001301008-26-000004 · wk-form4_1783023293.xml · nonDerivative · entry 1

Steele Robin Joan · CIK 0001301008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,055

F1 · shares: Represents shares underlying restricted stock units ("RSU") granted to the reporting person in lieu of cash compensation for service on the issuer's board of directors and its committees. Each RSU represents a contingent right to receive one share when vested. The RSUs vests on January 4, 2027.

SEC source: 0001301008-26-000002 · wk-form4_1781211524.xml · derivative · entry 1

Steele Robin Joan · CIK 0001301008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common stock · 10,000 shares

Expires 2036-06-11

F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer.

SEC source: 0001401914-25-000039 · wk-form4_1752177941.xml · derivative · entry 1

Steele Robin Joan · CIK 0001301008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,500

Underlying: Common stock · 4,500 shares

Expires 2035-07-09

F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer.

SEC source: 0001493152-24-023180 · ownership.xml · derivative · entry 1

Steele Robin Joan · CIK 0001301008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common stock · 40,000 shares

Expires 2034-06-05

F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer.

SEC source: 0001401914-23-000034 · wk-form4_1687398288.xml · derivative · entry 1

Steele Robin Joan · CIK 0001301008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common stock · 40,000 shares

Expires 2033-06-21

F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer.

SEC source: 0001401914-22-000070 · wf-form4_165610383624225.xml · derivative · entry 1

Steele Robin Joan · CIK 0001301008 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,000

Underlying: Common stock · 38,000 shares

Expires 2032-06-23

F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer.

SEC source: 0001401914-21-000103 · wf-form4_162456842200952.xml · derivative · entry 1

Steele Robin Joan · CIK 0001301008 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common stock · 30,000 shares

Expires 2031-06-24

F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer.

SEC source: 0001401914-20-000095 · wf-form4_159321932732948.xml · derivative · entry 1

Steele Robin Joan · CIK 0001301008 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common stock · 22,500 shares

Expires 2030-06-25

F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer.

SEC source: 0001401914-19-000062 · wf-form4_156053704682456.xml · derivative · entry 1

Steele Robin Joan · CIK 0001301008 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common stock · 22,500 shares

Expires 2029-06-13

F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer.

SEC source: 0001209191-18-042386 · doc4.xml · derivative · entry 1

Steele Robin Joan · CIK 0001301008 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2028-07-10

F1 · derivative.exercise_date: This option vests as to 1/3rd of the shares subject to this option on each of July 10, 2019, 2020 and 2021, subject to the reporting person's continued service to the issuer, and will become exercisable in full upon a change of control of the issuer.

SEC source: 0001209191-17-045984 · doc4.xml · derivative · entry 2

Steele Robin Joan · CIK 0001301008 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,200

Underlying: Common Stock · 2,200 shares

Expires 2027-07-19

F3 · derivative.exercise_price: The exercise price reported reflects the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017.

F4 · shares: Ms. Steele was awarded options to purchase shares of the Corporation's common stock in connection with her service as a member of the Board of Directors (the "Director Options") pursuant to the Corporation's 2014 Stock Incentive Plan and the Non-Employee Director Compensation Policy.

F5 · derivative.exercise_date: The Director Options will vest in equal annual installments over a three-year period measured from the date of grant, subject to Ms. Steele's continued service to the Corporation and will become exercisable in full upon a change of control of the Corporation.

SEC source: 0001209191-17-045984 · doc4.xml · nonDerivative · entry 1

Steele Robin Joan · CIK 0001301008 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By The Robin J. Steele Trust DTD 1/30/2015

Disclosed balance after: 246,171

F1 · price: In exchange for the issuance of shares of common stock and options to purchase shares of common stock of Dare Bioscience, Inc. (the "Corporation"), the Corporation acquired all of the issued and outstanding shares of common stock of Dare Bioscience Operations, Inc. ("Dare Operations") pursuant to the terms of a Stock Purchase Agreement, dated March 19, 2017, by and between the Corporation, Dare Operations and certain equityholders of Dare Operations party thereto, as filed with the Securities and Exchange Commission on Form 8-K on March 20, 2017 (such exchanges and issuances, the "Transaction").

F2 · price: The shares of common stock of the Corporation reported reflect the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017. These shares of common stock of the Corporation were received in connection with the Transaction in exchange for 1,212,685 shares of Dare Operations. On the effective date of the Transaction, the closing price of the common stock of the Corporation, as reported on The Nasdaq Capital Market, was $6.56 per share (on a post-split basis). Each share of common stock of Dare Operations was cancelled and exchanged for the right to receive 0.2029969047 shares of common stock of the Corporation (on a post-split basis).